Assessing Current Implementation of DSCSA Serialization Requirements 

Pharmaceutical Wholesalers Uncover Significant Progress in Barcode Assessments

As the November 2023 Drug Supply Chain Security Act (DSCSA) deadline approaches, the healthcare industry is working to apply barcodes in a standardized way to facilitate accurate movement of product across the supply chain.*

To obtain a view of industry’s progress, GS1 Healthcare US collaborated with AmerisourceBergen Corporation and McKesson Pharmaceutical to assess the barcodes on packages of “lowest saleable units” in their distribution facilities. Cardinal Health also conducted their own barcode assessment for homogeneous cases from pharmaceutical manufacturers.

Read the Results

…This understanding was really crucial for us in order to push for the highest level of compliance. Bad barcodes mean bad problems for the supply chain.” Quentin Dittman, Director of Operations Technology at Cardinal Health
  • To stay informed of future GS1 Healthcare US resources and updates, provide your contact details below:

*For information about the act, see the 2013 Drug Supply Chain Security Act

Disclaimer: GS1 US is the local GS1 Member Organization that supports implementation of the GS1 System in the United States. GS1 US employees are not representatives or agents of the U.S. FDA, and the content herein has not been reviewed, approved, or authorized by the U.S. FDA.